Buscar
Mostrando ítems 1-10 de 105
Physicochemical Characterization of La2(CO3)3.4H2O, a New and Promising Agent for the Treatment of Hyperphosphatemia
(Colegio de Farmaceuticos de la Provincia de Buenos Aires, 2011)
Deficiencia de vitamina D asociada a hiperfosfatemia en niños
(Colegio Médico del Pérú, 2021-08-23)
Los niños con deficiencia de vitamina D pueden tener fósforo normal o alto a pesar de tener una prueba de hormona paratiroidea (PTH) elevada. El pseudohipoparatiroidismo (PHP) se caracteriza por cursar con ...
Flow-through peritoneal dialysis in neonatal enema-induced hyperphosphatemia
(SPRINGER, 2010)
Fleet enemas are hypertonic solutions with an osmotic action and a high concentration of phosphate. When retained in the human body they have a great toxic potential, causing severe hydro-electrolyte disorders in children, ...
Effectiveness of a Feed Supplement in Advanced Stages of Feline Chronic Kidney Disease
(Universidade Federal do Rio Grande do Sul, 2016)
Hipopara-Red, Real Life Experience in 322 Patients with Hypoparathyroidism
(Oxford University Press, 2020-11)
Context:Hypoparathyroidism is a rare disease and as such, its natural history, long term complications and correct clinical management remain unclear.ObjectiveTo describe the natural history and clinical characteristics ...
Avaliação crítica do sevelamer no tratamento da hiperfosfatemia em pacientes com insuficiência renal crônica
(Associação Médica Brasileira, 2003-01-01)
OBJECTIVE: To evaluate in patients with chronic renal failure (CRF) the effectiveness and the costs of sevelamer, a cationic polymer calcium- and aluminum-free, that is a new gastrointestinal phosphate binder. METHODS: ...
Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system
(OXFORD UNIV PRESSOXFORD, 2012)
Background. Cardiac remodeling in uremia is characterized by left ventricular hypertrophy, interstitial fibrosis and microvascular disease. Cardiovascular disease is the leading cause of death in uremic patients, but ...